Bioventus Inc. operates through three primary business segments: Pain Treatments, Surgical Solutions, and Restorative Therapies. The Pain Treatments segment includes joint preservation products that treat chronic pain associated with osteoarthritis, as well as peripheral nerve stimulation (PNS) devices. The Restorative Therapies segment offers minimally invasive fracture treatments, including the Exogen ultrasound bone stimulation system. The Surgical Solutions segment provides bone graft substitutes and other surgical offerings. Originally established as a spin-off from Smith & Nephew's biologics division, Bioventus sells its products to healthcare institutions, physicians, and patients across the United States and internationally.
